Clinical Trials Logo

Neoplasm Metastasis clinical trials

View clinical trials related to Neoplasm Metastasis.

Filter by:

NCT ID: NCT03585673 Recruiting - Metastatic Cancer Clinical Trials

Docetaxel-polymeric Micelles(PM) and Oxaliplatin for Esophageal Carcinoma

DOSE
Start date: June 1, 2018
Phase: Phase 2
Study type: Interventional

Esophageal or esophageal-gastric junction squamous cell cancer has dismal prognosis. And still no promising chemotherapeutic drugs is existed. In this study, The investigators wanted to look at the effects and safety of first line docetaxel-PM and oxaliplatin weekly administration chemotherapy for the participants with inoperable or metastatic esophageal squamous cell carcinoma.

NCT ID: NCT03577665 Recruiting - Colorectal Cancer Clinical Trials

Curative Proton Beam Therapy for Patients With Liver Metastasis of Colorectal Cancer

Start date: May 21, 2018
Phase: N/A
Study type: Interventional

Proton alone therapy is performed -> 5 times a week, 7200 cGy / 15 fractions for 3 weeks total

NCT ID: NCT03570619 Active, not recruiting - Solid Tumor Clinical Trials

Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations

IMPACT
Start date: December 14, 2018
Phase: Phase 2
Study type: Interventional

This study will attempt to determine the efficacy of checkpoint inhibitor immunotherapy with nivolumab and ipilimumab combination therapy followed by nivolumab monotherapy in patients with metastatic prostate cancer and other tumor solid tumor histologies harboring loss of CDK12 function as well as monotherapy nivolumab treatment in patient with metastatic prostate cancer harboring loss of CDK12 function.

NCT ID: NCT03569241 Active, not recruiting - Prostate Cancer Clinical Trials

PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases

STORM
Start date: April 27, 2018
Phase: Phase 2
Study type: Interventional

A proportion of prostate cancer (PCa) patients develop relapse following curative local treatment. Regional nodal recurrence is an emerging clinical situation since the introduction of new molecular imaging methods in the restaging of recurrent prostate cancer. More specifically, a subgroup of these patients is being diagnosed with a recurrence confined to the regional lymph nodes and limited in number (oligorecurrence) using choline or PSMA PET-CT. As there are no specific treatment recommendations for these type of patients, different treatment approaches are currently used, mostly focusing on local ablative treatments using radiotherapy or surgery. These treatments are coined metastasisdirected therapy (MDT). MDT in combination with or without temporary ADT could delay the subsequent risk of progression, and even cure limited regional nodal recurrences. Consequently, lifelong palliative ADT, with its toxicity and excess in non-cancer mortality might be postponed. The proposed trial randomizes patients with oligorecurrent nodal prostate cancer following primary PCa treatment to either metastasis-directed therapy (MDT) (salvage lymph node dissection, sLND or stereotactic body radiotherapy, SBRT) or MDT plus whole pelvis radiotherapy (WPRT: 45 Gy in 25 fractions).

NCT ID: NCT03567538 Active, not recruiting - Lung Cancer Clinical Trials

National Register Studies in Thoracic Surgery

Start date: January 1, 2018
Phase:
Study type: Observational

The overall project aim is to study risk and outcomes following thoracic surgery by cross-linking high-quality national Swedish health-data registers for population-based investigations of individual level clinically relevant patient data.

NCT ID: NCT03566797 Recruiting - Clinical trials for Secondary Sclerosis Cholangitis in Critically Ill Patients

Secondary Sclerosis Cholangitis Prospective

SSCpro
Start date: July 20, 2018
Phase:
Study type: Observational

SC-CIP is increasing in patients after critical illness. Pathogenesis is still largely unclear. Gut microbiome composition, gut permeability, bacterial translocation, inflammation and/or genetic variants contribute to the pathogenesis The aim of this project is to study gut microbiome composition, gut permeability, bacterial translocation, inflammation, bile acid composition and genetic polymorphisms by conducting a prospective cohort study in patients with a high risk to develop SC-CIP.

NCT ID: NCT03566355 Recruiting - Colorectal Cancer Clinical Trials

Curative Proton Beam Therapy for Patients With Lung Metastasis of Colorectal Cancer

Start date: May 23, 2018
Phase: N/A
Study type: Interventional

Proton alone therapy is performed -> 5 times a week, 7200 cGy / 15 fractions for 3 weeks total

NCT ID: NCT03563326 Recruiting - Clinical trials for Metastases, Neoplasm

Intraperitoneal Infusion of EpCAM CAR-T Cell in Advanced Gastric Cancer With Peritoneal Metastasis (WCH-GC-CART)

Start date: August 30, 2018
Phase: Phase 1
Study type: Interventional

To investigate the safety and efficacy of intraperitoneal infusion of EpCAM CAR-T cell in advanced gastric cancer with peritoneal metastasis by a prospective nonrandomized controlled trial.

NCT ID: NCT03562234 Recruiting - Obesity Clinical Trials

The CLiFF Study: Change in Liver Function and Fat in Pre-operative Chemotherapy for Colorectal Liver Metastases

CLiFF
Start date: October 22, 2018
Phase:
Study type: Observational

The CLiFF Study will assess changes in liver function and liver fat in patients with colorectal liver metastases (CLM) undergoing pre-operative chemotherapy before liver resection. There will be no change to the standard treatment for CLM. The change in liver fat will be assessed using novel magnetic resonance techniques and the change in liver function will be measured using a newly-developed fully-licensed breath test to give the most accurate measure of liver function possible. Understanding if these changes are related or reversible will help to understand the relationship between obesity and cancer. This is an important issue, as obesity is now the second most common cause of cancer worldwide.

NCT ID: NCT03561896 Active, not recruiting - Clinical trials for Brain Metastases, Adult

Hypofractionated Brain Radiationcavity

Start date: January 2015
Phase: N/A
Study type: Interventional

Stereotactic radiosurgery or hypofractionated radiotherapy of the resection cavity after metastasectomy in cancer patients with brain metastases